SCHEMBL16339986

SCHEMBL16339986

NC(=O)c1c[nH]c2cccc(N)c12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
ATM Q13315 1/20 0.56
GAA P10253 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
PARP1 P09874 3/20 0.44
NR4A2 P43354 1/20 0.43
PIM1 P11309 1/20 0.42
PIM3 Q86V86 1/20 0.42
GPR84 Q9NQS5 1/20 0.42
CLK1 P49759 1/20 0.41
PBRM1 Q86U86 1/20 0.40
HTR1A P08908 2/20 0.39
HTR7 P34969 2/20 0.39
PDPK1 O15530 1/20 0.39
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
DNMT1 P26358 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21037791 0.81 NR4A2 (0.65) ALDH1A1ATMGAANPSR1PARP1
SCHEMBL10321304 0.81 ALDH1A1 (0.54) ALDH1A1ATMGAANPSR1PARP1
SCHEMBL26250363 0.80 NR4A2 (0.68) ALDH1A1ATMGAANR4A2PIM3
SCHEMBL27275844 0.80 NR4A2 (0.42) ALDH1A1ATMGAANPSR1NR4A2
SCHEMBL3631203 0.77 ALDH1A1 (0.50) ALDH1A1ATMGAANPSR1PARP1
SCHEMBL5102654 0.77 HTR2A (0.52) ALDH1A1ATMPARP1NR4A2CLK1
SCHEMBL2588267 0.74 ALDH1A1 (0.50) ALDH1A1ATMGAANPSR1PARP1
SCHEMBL29926543 0.74 ALDH1A1 (0.50) ALDH1A1ATMGAANPSR1PARP1
SCHEMBL29335910 0.74 HTR2A (0.43) NR4A2HTR1AHTR7
SCHEMBL5269870 0.73 HTR2C (0.47) ALDH1A1GAANPSR1CLK1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3013337-A1 PRIMARY CARBOXAMIDES AS BTK INHIBITORS Abbvie Inc. (US) 2016-05-04 EP disclosed
WO-2014210255-A1 PRIMARY CARBOXAMIDES AS BTK INHIBITORS ABBVIE INC. (US) 2014-12-31 WO disclosed